Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.78 |
| ▸ | GAA | P10253 | 2/20 | 0.75 |
| ▸ | MAPT | P10636 | 5/20 | 0.64 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.64 |
| ▸ | NR1I2 | O75469 | 1/20 | 0.61 |
| ▸ | LMNA | P02545 | 2/20 | 0.59 |
| ▸ | POLB | P06746 | 1/20 | 0.59 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.59 |
| ▸ | HPGD | P15428 | 1/20 | 0.57 |
| ▸ | RAB9A | P51151 | 1/20 | 0.57 |
| ▸ | MAOB | P27338 | 7/20 | 0.56 |
| ▸ | MAOA | P21397 | 1/20 | 0.53 |
| ▸ | HRH3 | Q9Y5N1 | 1/20 | 0.53 |
| ▸ | RECQL | P46063 | 1/20 | 0.52 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5114223 | 0.90 | L3MBTL1 (0.81) | L3MBTL1GAAMAPTALDH1A1LMNA | |
| SCHEMBL834525 | 0.90 | L3MBTL1 (0.88) | L3MBTL1GAAMAPTALDH1A1LMNA | |
| SCHEMBL3044200 | 0.89 | L3MBTL1 (0.68) | L3MBTL1GAAMAPTALDH1A1NR1I2 | |
| SCHEMBL28855980 | 0.89 | L3MBTL1 (0.68) | L3MBTL1GAAMAPTALDH1A1NR1I2 | |
| SCHEMBL3053864 | 0.89 | L3MBTL1 (0.68) | L3MBTL1GAAMAPTALDH1A1NR1I2 | |
| SCHEMBL7609908 | 0.89 | L3MBTL1 (0.85) | L3MBTL1GAAMAPTALDH1A1LMNA | |
| SCHEMBL18868405 | 0.88 | L3MBTL1 (1.00) | L3MBTL1GAAMAPTALDH1A1LMNA | |
| SCHEMBL3046764 | 0.86 | L3MBTL1 (0.75) | L3MBTL1GAAMAPTALDH1A1LMNA | |
| SCHEMBL1092185 | 0.84 | L3MBTL1 (0.85) | L3MBTL1GAAMAPTALDH1A1LMNA | |
| SCHEMBL8672706 | 0.84 | L3MBTL1 (0.78) | L3MBTL1GAAMAPTALDH1A1LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 59 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| JP-9169699-A | — | — | None | — | — | JP | disclosed |
| CN-118530734-A | Liquid crystal aligning agent, liquid crystal alignment film, liquid crystal element, polymer, and compound | JSR株式会社 | 2024-08-23 | — | — | CN | disclosed |
| CN-117751113-A | Aromatic acetylene derivative and preparation method and application thereof | 浙江海正药业股份有限公司 | 2024-03-22 | — | — | CN | disclosed |
| CN-117616070-A | Emulsion preparation from polydimethylsiloxane mixtures by emulsion polymerization and influence on the formation of cyclics in the emulsion product | 瓦克麦特罗克化学私营有限责任公司 | 2024-02-27 | — | — | CN | disclosed |
| US-11731967-B2 | Inhibitors of TRIM33 and methods of use | DANA-FARBER CANCER INSTITUTE, INC. (US) | 2023-08-22 | — | — | US | disclosed |
| US-10351523-B2 | UV-absorbing compounds with at least one reactive hydrogen | ISP INVESTMENTS LLC | 2019-07-16 | — | — | US | disclosed |
| US-10351523-B2 | UV-absorbing compounds with at least one reactive hydrogen | ISP INVESTMENTS LLC | 2019-07-16 | — | — | US | disclosed |
| US-20180099927-A1 | UV-ABSORBING COMPOUNDS WITH AT LEAST ONE REACTIVE HYDROGEN | ISP INVESTMENTS LLC (US) | 2018-04-12 | — | — | US | disclosed |
| US-20180099927-A1 | UV-ABSORBING COMPOUNDS WITH AT LEAST ONE REACTIVE HYDROGEN | ISP INVESTMENTS LLC (US) | 2018-04-12 | — | — | US | disclosed |
| US-20180099927-A1 | UV-ABSORBING COMPOUNDS WITH AT LEAST ONE REACTIVE HYDROGEN | ISP INVESTMENTS LLC (US) | 2018-04-12 | — | — | US | disclosed |
| EP-1067108-A2 | Process for producing aryloxyacetic acids | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2001-01-10 | — | — | EP | disclosed |
| US-5892096-A | CYANOACRYLIC DYES FOR PHOTORESISTS | BREWER SCIENCE, INC. (US) | 1999-04-06 | — | — | US | disclosed |
| US-5728706-A | ENDOTHELIN ANTAGONISTS | TANABE SEIYAKU CO., LTD. (JP) | 1998-03-17 | — | — | US | disclosed |
| EP-0658548-B1 | Benzenesulfonamide derivative and process for preparing thereof | TANABE SEIYAKU CO (JP) | 1997-11-19 | — | — | EP | disclosed |
| US-5688987-A | PHOTORESISTS FOR SEMICONDUCTOR APPLICATIONS, ANTIREFLECTIVE COATINGS | BREWER SCIENCE, INC. (US) | 1997-11-18 | — | — | US | disclosed |
| JP-H09169699-A | NEW DIBENZOYLMETHANE DERIVATIVE AND ITS PRODUCTION | OSAKA ORGANIC CHEM IND LTD | 1997-06-30 | — | — | JP | disclosed |
| US-5589478-A | ENDOTHELIN ANTAGONISTS | TANABE SEIYAKU CO., LTD. (JP) | 1996-12-31 | — | — | US | disclosed |
| EP-0658548-A1 | Benzenesulfonamide derivative and process for preparing thereof | TANABE SEIYAKU CO., LTD. (JP) | 1995-06-21 | — | — | EP | disclosed |
| US-5053509-A | Microbiocides; AIDS | LABORATOIRE ROGER BELLON (FR) | 1991-10-01 | — | — | US | disclosed |
| US-4565769-A | Polymeric sensitizers for photopolymer composition | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 1986-01-21 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11731967-B2 | Inhibitors of TRIM33 and methods of use | TRIM33, TRIM28, TRIM4 | L3MBTL1 487/4885GAA 1769/4885MAPT 1086/4885 |
| US-10351523-B2 | UV-absorbing compounds with at least one reactive hydrogen | ERCC1, ERCC4, UNG | L3MBTL1 4053/4885GAA 921/4885MAPT 596/4885 |
| US-20180099927-A1 | UV-ABSORBING COMPOUNDS WITH AT LEAST ONE REACTIVE HYDROGEN | ERCC1, ERCC4, UNG | L3MBTL1 4053/4885GAA 921/4885MAPT 596/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.